Qilu Pharmaceutical Co., Ltd.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference 3764e8ea24
Drug names232First applicant · distinct drug namesAcceptance records545First applicant · distinct acceptance numbersUnder-review numbers37First applicant · current under-review listCo-applicant records97Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
545 acceptance records as first applicant, grouped into 232 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 12 records · Latest accepted 2026/11/09
New drug · 7Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600151 | New drug | 2026/11/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600150 | New drug | 2026/11/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600149 | New drug | 2026/11/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501772 | Supplement | 2025/09/05 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2401490 | Supplement | 2024/09/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2401489 | Supplement | 2024/09/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2401488 | Supplement | 2024/09/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2300779 | Supplement | 2023/04/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200610 | New drug | 2022/08/23 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200609 | New drug | 2022/08/23 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200188 | New drug | 2022/03/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200187 | New drug | 2022/03/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/11/05
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2601229 | New drug | 2026/11/05 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Crisaborole Ointment 4 records · Latest accepted 2026/10/29
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601976 | Supplement | 2026/10/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2601975 | Supplement | 2026/10/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301244 | Generic | 2023/05/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301243 | Generic | 2023/05/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 6 records · Latest accepted 2026/08/27
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYSB2600265 | Supplement | 2026/08/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2600237 | Supplement | 2026/08/04 | Qilu Pharmaceutical Co., Ltd.; Jiangsu Tai Kang Biopharmaceuticals Co., Ltd. romanized | CDE ↗ |
| CYSB2600153 | Supplement | 2026/05/20 | Qilu Pharmaceutical Co., Ltd.; Jiangsu Tai Kang Biopharmaceuticals Co., Ltd. romanized | CDE ↗ |
| CYSB2600129 | Supplement | 2026/04/24 | Qilu Pharmaceutical Co., Ltd.; Jiangsu Tai Kang Biopharmaceuticals Co., Ltd. romanized | CDE ↗ |
| CYSB2600005 | Supplement | 2026/01/08 | Qilu Pharmaceutical Co., Ltd.; Jiangsu Tai Kang Biopharmaceuticals Co., Ltd. romanized | CDE ↗ |
| CYSB2500256 | Supplement | 2025/09/30 | Qilu Pharmaceutical Co., Ltd.; Jiangsu Tai Kang Biopharmaceuticals Co., Ltd. romanized | CDE ↗ |
No verified English name 4 records · Latest accepted 2026/08/17
Supplement · 1New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2600210 | Supplement | 2026/08/17 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2600274 | New drug | 2026/02/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500585 | New drug | 2025/07/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500519 | New drug | 2025/06/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Idebenone Tablets 1 records · Latest accepted 2026/08/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2602008 | Generic | 2026/08/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 6 records · Latest accepted 2026/07/24
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2600109 | New drug | 2026/07/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600108 | New drug | 2026/07/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2600107 | New drug | 2026/07/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200318 | New drug | 2022/05/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200317 | New drug | 2022/05/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200316 | New drug | 2022/05/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/07/06
New drug · 2
No verified English name 11 records · Latest accepted 2026/07/06
Supplement · 3New drug · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2600211 | Supplement | 2026/07/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2600168 | Supplement | 2026/06/04 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2600167 | Supplement | 2026/06/04 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2600531 | New drug | 2026/05/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2600530 | New drug | 2026/05/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2600528 | New drug | 2026/05/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2600527 | New drug | 2026/05/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2501421 | New drug | 2025/12/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2501420 | New drug | 2025/12/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500782 | New drug | 2025/07/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500781 | New drug | 2025/07/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/07/02
Generic · 2
No verified English name 4 records · Latest accepted 2026/06/25
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSS2600102 | New drug | 2026/06/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSS2600101 | New drug | 2026/06/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2400754 | New drug | 2024/11/08 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2400753 | New drug | 2024/11/08 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/06/09
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2600619 | New drug | 2026/06/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/06/04
New drug · 2
No verified English name 5 records · Latest accepted 2026/06/02
Supplement · 1New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2600100 | Supplement | 2026/06/02 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2600211 | New drug | 2026/02/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2501120 | New drug | 2025/12/23 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500284 | New drug | 2025/04/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2400011 | New drug | 2024/01/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/05/29
Supplement · 2New drug · 1
No verified English name 3 records · Latest accepted 2026/05/15
New drug · 2Supplement · 1
No verified English name 12 records · Latest accepted 2026/05/14
New drug · 11Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2600528 | New drug | 2026/05/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2600336 | New drug | 2026/03/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSB2600049 | Supplement | 2026/03/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2600273 | New drug | 2026/02/28 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2600092 | New drug | 2026/01/17 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500992 | New drug | 2025/11/21 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500587 | New drug | 2025/07/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500467 | New drug | 2025/06/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500217 | New drug | 2025/03/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500085 | New drug | 2025/01/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500028 | New drug | 2025/01/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2300477 | New drug | 2023/07/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/05/09
New drug · 3
No verified English name 1 records · Latest accepted 2026/05/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2600058 | Generic | 2026/05/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Cisplatin Injection 1 records · Latest accepted 2026/04/24
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600823 | Supplement | 2026/04/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 4 records · Latest accepted 2026/04/22
Supplement · 1Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600786 | Supplement | 2026/04/22 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101843 | Generic | 2021/10/12 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101842 | Generic | 2021/10/12 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2101841 | Generic | 2021/10/12 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 7 records · Latest accepted 2026/04/15
Supplement · 5New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYSB2600121 | Supplement | 2026/04/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2600094 | Supplement | 2026/03/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500277 | Supplement | 2025/10/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500276 | Supplement | 2025/10/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2400135 | Supplement | 2024/05/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSS2101027 | New drug | 2021/09/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSS2101023 | New drug | 2021/08/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 5 records · Latest accepted 2026/03/31
Supplement · 4New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYSB2600112 | Supplement | 2026/03/31 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500328 | Supplement | 2025/12/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500308 | Supplement | 2025/12/02 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2400056 | Supplement | 2024/03/01 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSS2200044 | New drug | 2022/04/28 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/03/30
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2600363 | New drug | 2026/03/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/03/26
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2600353 | New drug | 2026/03/26 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Letermovir Injection 4 records · Latest accepted 2026/03/19
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600542 | Supplement | 2026/03/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2600541 | Supplement | 2026/03/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2402551 | Generic | 2024/08/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2402548 | Generic | 2024/08/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 5 records · Latest accepted 2026/03/19
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYSB2600109 | Supplement | 2026/03/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500316 | Supplement | 2025/12/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500017 | Supplement | 2025/01/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2200250 | Supplement | 2022/10/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2101086 | Supplement | 2021/06/22 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/03/18
New drug · 2
No verified English name 4 records · Latest accepted 2026/03/16
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2600627 | Generic | 2026/03/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2600626 | Generic | 2026/03/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2404025 | Generic | 2024/11/23 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2404024 | Generic | 2024/11/23 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/03/12
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600305 | New drug | 2026/03/12 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/03/10
Supplement · 1New drug · 1
No verified English name 6 records · Latest accepted 2026/03/06
Supplement · 2New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2600070 | Supplement | 2026/03/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2600069 | Supplement | 2026/03/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500263 | New drug | 2025/03/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500262 | New drug | 2025/03/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400108 | New drug | 2024/01/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400107 | New drug | 2024/01/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/03/02
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYSB2600085 | Supplement | 2026/03/02 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 5 records · Latest accepted 2026/02/26
New drug · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2600235 | New drug | 2026/02/26 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2600234 | New drug | 2026/02/26 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2600233 | New drug | 2026/02/26 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2501250 | New drug | 2025/11/12 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2501249 | New drug | 2025/11/12 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2026/02/13
New drug · 3
No verified English name 3 records · Latest accepted 2026/02/09
New drug · 3
No verified English name 1 records · Latest accepted 2026/01/29
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2600153 | New drug | 2026/01/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Ceftazidime And Avibactam Sodium For Injection 3 records · Latest accepted 2026/01/22
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2600131 | Supplement | 2026/01/22 | Qilu Pharmaceutical Co., Ltd.; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2501612 | Supplement | 2025/08/13 | Qilu Pharmaceutical Co., Ltd.; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2302165 | Supplement | 2023/09/23 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Palonosetron Hydrochloride Soft Capsules 2 records · Latest accepted 2026/01/20
Generic · 2
No verified English name 2 records · Latest accepted 2026/01/17
New drug · 2
No verified English name 1 records · Latest accepted 2026/01/04
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2600006 | New drug | 2026/01/04 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/12/30
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2501169 | New drug | 2025/12/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 8 records · Latest accepted 2025/12/03
Supplement · 6New drug · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2500229 | Supplement | 2025/12/03 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSB2500228 | Supplement | 2025/12/03 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSB2500227 | Supplement | 2025/12/03 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500285 | New drug | 2025/04/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSB2500036 | Supplement | 2025/03/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSB2500035 | Supplement | 2025/03/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSB2500034 | Supplement | 2025/03/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2300238 | New drug | 2023/04/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Budesonide Gastro-Resistant Capsules 1 records · Latest accepted 2025/11/25
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504066 | Generic | 2025/11/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/11/21
New drug · 3
No verified English name 14 records · Latest accepted 2025/11/19
Supplement · 2New drug · 12
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2500222 | Supplement | 2025/11/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2400472 | New drug | 2024/07/20 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2400193 | New drug | 2024/03/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2300305 | New drug | 2023/05/05 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2200550 | New drug | 2022/11/01 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2200439 | New drug | 2022/09/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2200251 | New drug | 2022/06/08 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2200193 | New drug | 2022/04/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2200124 | New drug | 2022/03/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2200076 | New drug | 2022/02/08 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSB2200015 | Supplement | 2022/01/28 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2200043 | New drug | 2022/01/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101480 | New drug | 2021/12/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101122 | New drug | 2021/06/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Enzalutamide Soft Capsules 2 records · Latest accepted 2025/11/19
Supplement · 1Generic · 1
Pemetrexed Disodium for Injection 2 records · Latest accepted 2025/11/19
Supplement · 2
Triptorelin Acetate For Injection 1 records · Latest accepted 2025/11/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2504016 | Generic | 2025/11/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/11/06
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500949 | New drug | 2025/11/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/10/30
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500934 | New drug | 2025/10/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/10/23
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500921 | New drug | 2025/10/23 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 6 records · Latest accepted 2025/10/16
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2501132 | New drug | 2025/10/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2501130 | New drug | 2025/10/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400600 | New drug | 2024/06/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400599 | New drug | 2024/06/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400598 | New drug | 2024/06/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400597 | New drug | 2024/06/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/10/14
Generic · 3
Dalteparin Sodium Injection 2 records · Latest accepted 2025/10/14
Supplement · 2
No verified English name 1 records · Latest accepted 2025/10/10
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYSB2500265 | Supplement | 2025/10/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/09/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501954 | Supplement | 2025/09/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/09/22
New drug · 2
No verified English name 2 records · Latest accepted 2025/09/06
New drug · 1Supplement · 1
No verified English name 6 records · Latest accepted 2025/09/06
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500967 | New drug | 2025/09/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500966 | New drug | 2025/09/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500965 | New drug | 2025/09/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2401196 | New drug | 2024/11/07 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2401195 | New drug | 2024/11/07 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2401194 | New drug | 2024/11/07 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 9 records · Latest accepted 2025/09/06
New drug · 6Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500963 | New drug | 2025/09/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500962 | New drug | 2025/09/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500961 | New drug | 2025/09/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500842 | New drug | 2025/08/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500841 | New drug | 2025/08/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500840 | New drug | 2025/08/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2404403 | Generic | 2024/12/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2404402 | Generic | 2024/12/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2404401 | Generic | 2024/12/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/09/04
Generic · 2
No verified English name 11 records · Latest accepted 2025/08/28
New drug · 11
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500906 | New drug | 2025/08/28 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500905 | New drug | 2025/08/28 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500904 | New drug | 2025/08/28 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500903 | New drug | 2025/08/28 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500901 | New drug | 2025/08/28 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2400095 | New drug | 2024/09/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2400094 | New drug | 2024/09/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200888 | New drug | 2022/11/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200887 | New drug | 2022/11/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200326 | New drug | 2022/05/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200325 | New drug | 2022/05/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Ruxolitinib Phosphate Tablets 6 records · Latest accepted 2025/08/15
Generic · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503012 | Generic | 2025/08/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2503011 | Generic | 2025/08/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2503010 | Generic | 2025/08/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2501525 | Generic | 2025/04/22 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2501524 | Generic | 2025/04/22 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2501523 | Generic | 2025/04/22 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/08/13
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500693 | New drug | 2025/08/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/08/05
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500659 | New drug | 2025/08/05 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Ponatinib Tablets 1 records · Latest accepted 2025/08/01
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502789 | Generic | 2025/08/01 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 4 records · Latest accepted 2025/07/31
New drug · 2Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500639 | New drug | 2025/07/31 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500638 | New drug | 2025/07/31 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500150 | Supplement | 2025/07/04 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500149 | Supplement | 2025/07/04 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Edoxaban Tosilate Tablets 6 records · Latest accepted 2025/07/31
Supplement · 3Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501513 | Supplement | 2025/07/31 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501512 | Supplement | 2025/07/31 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501511 | Supplement | 2025/07/31 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2302693 | Generic | 2023/10/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2302692 | Generic | 2023/10/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2302691 | Generic | 2023/10/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/07/12
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500188 | Supplement | 2025/07/12 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/07/07
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500545 | New drug | 2025/07/07 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Nintedanib Esilate Soft Capsules 4 records · Latest accepted 2025/07/01
Supplement · 2Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2501289 | Supplement | 2025/07/01 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2501288 | Supplement | 2025/07/01 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2200280 | Generic | 2022/02/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2200279 | Generic | 2022/02/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 6 records · Latest accepted 2025/06/27
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500625 | New drug | 2025/06/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500624 | New drug | 2025/06/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500548 | New drug | 2025/06/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2500547 | New drug | 2025/06/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300624 | New drug | 2023/06/08 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300623 | New drug | 2023/06/08 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/06/20
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502234 | Generic | 2025/06/20 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 5 records · Latest accepted 2025/06/17
Supplement · 2New drug · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHB2500166 | Supplement | 2025/06/17 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHB2500016 | Supplement | 2025/01/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300160 | New drug | 2023/02/03 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300159 | New drug | 2023/02/03 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300158 | New drug | 2023/02/03 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 5 records · Latest accepted 2025/06/10
New drug · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2500466 | New drug | 2025/06/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2500084 | New drug | 2025/01/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2400192 | New drug | 2024/03/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2300331 | New drug | 2023/05/12 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2101072 | New drug | 2021/05/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2025/06/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2502034 | Generic | 2025/06/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 10 records · Latest accepted 2025/05/29
Supplement · 10
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYSB2500124 | Supplement | 2025/05/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500037 | Supplement | 2025/02/07 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500023 | Supplement | 2025/01/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2500022 | Supplement | 2025/01/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2300146 | Supplement | 2023/07/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2200165 | Supplement | 2022/06/28 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2200095 | Supplement | 2022/03/22 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2101303 | Supplement | 2021/12/23 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2101171 | Supplement | 2021/08/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYSB2100040 | Supplement | 2021/01/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Eltrombopag Olamine Tablets 2 records · Latest accepted 2025/05/28
Supplement · 1Generic · 1
No verified English name 2 records · Latest accepted 2025/05/19
New drug · 2
No verified English name 5 records · Latest accepted 2025/05/14
Supplement · 4New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSB2500066 | Supplement | 2025/05/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSB2500065 | Supplement | 2025/05/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSB2500064 | Supplement | 2025/05/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSB2500063 | Supplement | 2025/05/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXSL2400221 | New drug | 2024/04/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/04/03
Supplement · 2New drug · 1
No verified English name 2 records · Latest accepted 2025/03/11
New drug · 2
Esflurbiprofen Patches 1 records · Latest accepted 2025/02/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2500032 | Generic | 2025/02/07 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Fluticasone Furoate Nasal Spray 1 records · Latest accepted 2025/01/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500462 | Generic | 2025/01/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/01/10
Supplement · 1New drug · 1
No verified English name 2 records · Latest accepted 2025/01/07
New drug · 2
No verified English name 1 records · Latest accepted 2025/01/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2500029 | Generic | 2025/01/03 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Safinamide Methansulfonate Tablets 2 records · Latest accepted 2024/12/27
Generic · 2
Oxybuprocaine Hydrochloride Eye Drops 1 records · Latest accepted 2024/11/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2404073 | Generic | 2024/11/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Emtricitabine and tenofovir disoproxil fumarate tablets 1 records · Latest accepted 2024/11/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401935 | Supplement | 2024/11/21 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/11/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYSB2400304 | Supplement | 2024/11/21 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Formoterol Fumarate Inhalation Solution 1 records · Latest accepted 2024/11/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2403814 | Generic | 2024/11/08 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2024/10/25
Supplement · 2New drug · 1
Entecavir Tablets 1 records · Latest accepted 2024/10/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2401606 | Supplement | 2024/10/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/09/26
Supplement · 2
Emtricitabine and Tenofovir Alafenamide Fumarate Tablets（Ⅱ） 2 records · Latest accepted 2024/09/25
Supplement · 1Generic · 1
Relugolix Tablets 2 records · Latest accepted 2024/09/19
Generic · 2
No verified English name 3 records · Latest accepted 2024/09/14
New drug · 3
Olmesartan Medoxomil Tablets 2 records · Latest accepted 2024/08/20
Supplement · 2
Letermovir Tablets 1 records · Latest accepted 2024/08/14
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402627 | Generic | 2024/08/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Mirabegron Extended-release Tablets 2 records · Latest accepted 2024/08/09
Supplement · 1Generic · 1
Avatrombopag Maleate Tablets 2 records · Latest accepted 2024/08/08
Supplement · 1Generic · 1
No verified English name 1 records · Latest accepted 2024/08/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2400159 | Generic | 2024/08/03 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Lusutrombopag Tablets 1 records · Latest accepted 2024/07/31
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402432 | Generic | 2024/07/31 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2024/07/19
New drug · 3
Brexpiprazole Orally Disintegrating Tablets 3 records · Latest accepted 2024/07/18
Generic · 3
Brexpiprazole Tablets 3 records · Latest accepted 2024/07/18
Generic · 3
Fluticasone Propionate Nasal Spray 1 records · Latest accepted 2024/07/12
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402147 | Generic | 2024/07/12 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/07/10
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400679 | New drug | 2024/07/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 4 records · Latest accepted 2024/06/29
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2400642 | New drug | 2024/06/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400641 | New drug | 2024/06/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400640 | New drug | 2024/06/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2400639 | New drug | 2024/06/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 4 records · Latest accepted 2024/06/25
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2400129 | Generic | 2024/06/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHL2400128 | Generic | 2024/06/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHL2400127 | Generic | 2024/06/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHL2400126 | Generic | 2024/06/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Tofacitinib Citrate Extended Release tablets 2 records · Latest accepted 2024/05/11
Supplement · 2
No verified English name 2 records · Latest accepted 2024/05/09
Supplement · 2
Dronedarone Hydrochloride Tablets 1 records · Latest accepted 2024/04/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2401042 | Generic | 2024/04/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Olanzapine for Injection 2 records · Latest accepted 2024/04/08
Generic · 2
Entacapone,Levodopa and Carbidopa Tablets（Ⅱ） 1 records · Latest accepted 2024/04/03
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400999 | Generic | 2024/04/03 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/02/21
Generic · 2
No verified English name 2 records · Latest accepted 2024/02/07
New drug · 2
Parecoxib Sodium for Injection 1 records · Latest accepted 2024/01/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2400070 | Supplement | 2024/01/09 | Qilu Pharmaceutical Co., Ltd.; Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2024/01/04
Generic · 2
Agomelatine Tablets 1 records · Latest accepted 2023/12/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303379 | Generic | 2023/12/07 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) 1 records · Latest accepted 2023/12/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303369 | Generic | 2023/12/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/12/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2303370 | Generic | 2023/12/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/11/29
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2300822 | New drug | 2023/11/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/11/24
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2301310 | New drug | 2023/11/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Levofolinate Calcium for Injection 2 records · Latest accepted 2023/11/18
Supplement · 2
No verified English name 2 records · Latest accepted 2023/11/04
Supplement · 1New drug · 1
Ciclosporin Soft Capsules 2 records · Latest accepted 2023/11/01
Generic · 2
Ixazomib Citrate Capsules 3 records · Latest accepted 2023/10/17
Generic · 3
No verified English name 1 records · Latest accepted 2023/10/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2300129 | Generic | 2023/10/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Meloxicam injection 1 records · Latest accepted 2023/10/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2300128 | Generic | 2023/10/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/09/17
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSS2300077 | New drug | 2023/09/17 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Netupitant and Palonosetron Hydrochloride Capsules 1 records · Latest accepted 2023/09/16
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2302494 | Generic | 2023/09/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Bambuterol Hydrochloride Tablets 1 records · Latest accepted 2023/09/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350687 | Supplement | 2023/09/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/09/05
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300952 | New drug | 2023/09/05 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2023/09/05
Supplement · 1New drug · 2
No verified English name 4 records · Latest accepted 2023/08/29
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300924 | New drug | 2023/08/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300923 | New drug | 2023/08/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300922 | New drug | 2023/08/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2300921 | New drug | 2023/08/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/08/12
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSS2300066 | New drug | 2023/08/12 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Dapoxetine Hydrochloride Tablets 1 records · Latest accepted 2023/07/08
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301837 | Generic | 2023/07/08 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/07/06
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2300740 | New drug | 2023/07/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Ethyl Iosapentate Capsules 1 records · Latest accepted 2023/06/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2301609 | Generic | 2023/06/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Azithromycin Capsules 1 records · Latest accepted 2023/06/09
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350482 | Supplement | 2023/06/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/05/30
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2300380 | New drug | 2023/05/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2023/05/25
Generic · 2
No verified English name 1 records · Latest accepted 2023/05/19
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2300354 | New drug | 2023/05/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Tofacitinib Citrate Tablets 2 records · Latest accepted 2023/05/09
Supplement · 2
No verified English name 2 records · Latest accepted 2023/04/27
Supplement · 1New drug · 1
Lenalidomide Capsules 3 records · Latest accepted 2023/04/07
Supplement · 3
No verified English name 2 records · Latest accepted 2023/03/10
New drug · 2
No verified English name 2 records · Latest accepted 2023/02/01
New drug · 2
No verified English name 1 records · Latest accepted 2023/01/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300193 | Generic | 2023/01/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/01/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300194 | Generic | 2023/01/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Regorafenib Tablets 2 records · Latest accepted 2023/01/18
Generic · 2
Emtricitabine, Rilpivirine, and Tenofovir Alafenamide Tablets 1 records · Latest accepted 2023/01/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300165 | Generic | 2023/01/17 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Ganirelix Injection 1 records · Latest accepted 2023/01/17
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300153 | Generic | 2023/01/17 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/01/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300072 | Generic | 2023/01/11 | Qilu Pharmaceutical Co., Ltd.; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Tafamidis Meglumine Soft Capsules 1 records · Latest accepted 2023/01/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2300076 | Generic | 2023/01/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/01/10
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSS2300002 | New drug | 2023/01/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Carvedilol Tablets 3 records · Latest accepted 2023/01/05
Supplement · 3
Risperidone Orally Disintegrating Tablets 3 records · Latest accepted 2022/12/28
Supplement · 3
Macitentan Tablets 1 records · Latest accepted 2022/12/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2202096 | Generic | 2022/12/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Esomeprazole Sodium for Injection 2 records · Latest accepted 2022/12/24
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250766 | Supplement | 2022/12/24 | Qilu Pharmaceutical Co., Ltd.; Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | CDE ↗ |
| CYHB2151076 | Supplement | 2021/12/14 | Qilu Pharmaceutical Co., Ltd.; Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | CDE ↗ |
Azithromycin For Injection 2 records · Latest accepted 2022/12/08
Supplement · 2
No verified English name 2 records · Latest accepted 2022/11/23
New drug · 2
No verified English name 4 records · Latest accepted 2022/11/02
New drug · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHS2200060 | New drug | 2022/11/02 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHS2200059 | New drug | 2022/11/02 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200015 | New drug | 2022/01/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200014 | New drug | 2022/01/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Dapagliflozin Tablets 2 records · Latest accepted 2022/11/01
Generic · 2
Bendamustine Hydrochloride Injection 1 records · Latest accepted 2022/10/21
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201798 | Generic | 2022/10/21 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/10/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201695 | Generic | 2022/10/11 | Qilu Pharmaceutical Co., Ltd.; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Aripiprazole Orally Disintegrating tablets 1 records · Latest accepted 2022/10/11
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201848 | Supplement | 2022/10/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Cefpodoxime Proxetil Tablets 1 records · Latest accepted 2022/10/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201687 | Generic | 2022/10/10 | Qilu Pharmaceutical Co., Ltd.; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/09/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201637 | Generic | 2022/09/29 | Qilu Pharmaceutical Co., Ltd.; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/09/24
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2200479 | New drug | 2022/09/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Rivaroxaban Tablets 1 records · Latest accepted 2022/09/23
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201744 | Supplement | 2022/09/23 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/09/02
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2200433 | New drug | 2022/09/02 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 6 records · Latest accepted 2022/08/30
New drug · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2200635 | New drug | 2022/08/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200634 | New drug | 2022/08/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200633 | New drug | 2022/08/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200241 | New drug | 2022/04/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200240 | New drug | 2022/04/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200239 | New drug | 2022/04/18 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Risperidone Tablets 2 records · Latest accepted 2022/08/18
Supplement · 2
No verified English name 4 records · Latest accepted 2022/08/16
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201310 | Generic | 2022/08/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201308 | Generic | 2022/08/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201307 | Generic | 2022/08/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2201306 | Generic | 2022/08/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Cetrorelix Acetate for Injection 1 records · Latest accepted 2022/08/10
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201273 | Generic | 2022/08/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Sildenafil Citrate Oral Disintegrating Tablets 1 records · Latest accepted 2022/08/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201214 | Generic | 2022/08/02 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Cefaclor Capsules 1 records · Latest accepted 2022/07/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201175 | Generic | 2022/07/29 | Qilu Pharmaceutical Co., Ltd.; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2022/07/29
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201173 | Generic | 2022/07/29 | Qilu Pharmaceutical Co., Ltd.; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Cefdinir Capsules 1 records · Latest accepted 2022/07/28
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201162 | Generic | 2022/07/28 | Qilu Pharmaceutical Co., Ltd.; Qi Lu An Ti Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Lenvatinib Mesilate Capsules 4 records · Latest accepted 2022/07/28
Supplement · 3New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2201298 | Supplement | 2022/07/28 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CXHL2200052 | New drug | 2022/01/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2102025 | Supplement | 2021/10/21 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2102024 | Supplement | 2021/10/21 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Alprazolam Tablets 1 records · Latest accepted 2022/07/14
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250437 | Supplement | 2022/07/14 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Pregabalin Extended release Tablets 1 records · Latest accepted 2022/07/11
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHL2200057 | Generic | 2022/07/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/06/16
New drug · 2
No verified English name 2 records · Latest accepted 2022/06/16
New drug · 2
Omega-3-acid ethyl ester 90 Soft Capsules 1 records · Latest accepted 2022/06/13
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200808 | Generic | 2022/06/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/06/09
New drug · 2
Fosaprepitant Dimeglumine for Injection 1 records · Latest accepted 2022/05/24
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200811 | Supplement | 2022/05/24 | Qilu Pharmaceutical Co., Ltd.; Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | CDE ↗ |
Dolutegravir Sodium Tablets 1 records · Latest accepted 2022/04/24
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200638 | Generic | 2022/04/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Palbociclib Tablets 3 records · Latest accepted 2022/04/18
Generic · 3
No verified English name 3 records · Latest accepted 2022/04/12
Supplement · 3
Riociguat Tablets 3 records · Latest accepted 2022/03/25
Generic · 3
Amikacin Sulfate injection 1 records · Latest accepted 2022/03/25
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2250187 | Supplement | 2022/03/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2022/03/22
New drug · 2
No verified English name 2 records · Latest accepted 2022/03/14
New drug · 2
Paliperidone Palmitate Injection 3 records · Latest accepted 2022/03/14
Generic · 3
Fulvestrant Injection 1 records · Latest accepted 2022/02/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200369 | Generic | 2022/02/23 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Sildenafil Citrate Tablets 1 records · Latest accepted 2022/02/15
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200327 | Supplement | 2022/02/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Capecitabine Tablets 2 records · Latest accepted 2022/01/26
Supplement · 2
No verified English name 1 records · Latest accepted 2022/01/25
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2200047 | New drug | 2022/01/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Pranoprofen Eye Drops 1 records · Latest accepted 2022/01/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2200019 | Generic | 2022/01/07 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Octreotide Acetate Microspheres for Injection 2 records · Latest accepted 2022/01/07
Generic · 2
No verified English name 1 records · Latest accepted 2021/12/07
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2101467 | New drug | 2021/12/07 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/11/30
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2151045 | Supplement | 2021/11/30 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Nilotinib Capsules 2 records · Latest accepted 2021/11/08
Generic · 2
Probucol Tablets 1 records · Latest accepted 2021/11/01
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150970 | Supplement | 2021/11/01 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/10/11
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2101354 | New drug | 2021/10/11 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2021/09/16
Supplement · 2
Docetaxel Injection 2 records · Latest accepted 2021/08/05
Supplement · 2
No verified English name 2 records · Latest accepted 2021/07/24
New drug · 2
No verified English name 1 records · Latest accepted 2021/07/08
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2101176 | New drug | 2021/07/08 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2021/06/21
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101411 | Supplement | 2021/06/21 | Qilu Pharmaceutical Co., Ltd.; Shandong An Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2101410 | Supplement | 2021/06/21 | Qilu Pharmaceutical Co., Ltd.; Shandong An Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 2 records · Latest accepted 2021/06/21
Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2101413 | Supplement | 2021/06/21 | Qilu Pharmaceutical Co., Ltd.; Shandong An Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHB2101412 | Supplement | 2021/06/21 | Qilu Pharmaceutical Co., Ltd.; Shandong An Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
Emtricitabine and Tenofovir Alafenamide Fumarate Tablets（Ⅰ） 1 records · Latest accepted 2021/06/07
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101267 | Generic | 2021/06/07 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Carboplatin Injection 3 records · Latest accepted 2021/06/01
Supplement · 3
No verified English name 1 records · Latest accepted 2021/05/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101211 | Generic | 2021/05/26 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/05/26
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101212 | Generic | 2021/05/26 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Linagliptin Tablets 1 records · Latest accepted 2021/05/19
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101183 | Generic | 2021/05/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Cefuroxime Sodium for Injection 4 records · Latest accepted 2021/05/13
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2150589 | Supplement | 2021/05/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2150588 | Supplement | 2021/05/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2150587 | Supplement | 2021/05/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2150585 | Supplement | 2021/05/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/04/27
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2101104 | Generic | 2021/04/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Cefoperazone Sodium and Sulbactam Sodium for Injection 2 records · Latest accepted 2021/04/10
Supplement · 2
No verified English name 1 records · Latest accepted 2021/02/20
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2100059 | New drug | 2021/02/20 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Nedaplatin For Injection 2 records · Latest accepted 2021/01/21
Supplement · 2
Piperacillin Sodium And Tazobactam Sodium For Injection 3 records · Latest accepted 2021/01/18
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100041 | Generic | 2021/01/18 | Qilu Pharmaceutical Co., Ltd.; Shandong An Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2100040 | Generic | 2021/01/11 | Qilu Pharmaceutical Co., Ltd.; Shandong An Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| CYHS2100039 | Generic | 2021/01/11 | Qilu Pharmaceutical Co., Ltd.; Shandong An Xin Pharmaceutical Co., Ltd. romanized | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/01/09
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXSL2100012 | New drug | 2021/01/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2021/01/09
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100023 | Generic | 2021/01/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Diquafosol Sodium Eye Drops 1 records · Latest accepted 2021/01/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100006 | Generic | 2021/01/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Dutasteride Soft Capsules 1 records · Latest accepted 2021/01/06
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2100014 | Generic | 2021/01/06 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Granisetron Hydrochloride injection 1 records · Latest accepted 2021/01/05
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2040058 | Supplement | 2021/01/05 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
13 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Marketing application approved: 1 applicationAccepted: 8 applicationsNo longer listed under review: 2 applicationsSupplement delivery: 1 applicationNotification delivery: 1 application
- 2026/11/09Accepted
No verified English name
CXHS2600151
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ - 2026/11/09Accepted
No verified English name
CXHS2600150
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ - 2026/11/09Accepted
No verified English name
CXHS2600149
Fact date: 2026/11/09 · Site observation date: 2026/11/10
View source ↗ - 2026/11/05Accepted
No verified English name
CXSL2601229
Fact date: 2026/11/05 · Site observation date: 2026/11/06
View source ↗ - 2026/10/29Accepted
Crisaborole Ointment
CYHB2601976
Fact date: 2026/10/29 · Site observation date: 2026/10/30
View source ↗ - 2026/10/29Accepted
Crisaborole Ointment
CYHB2601975
Fact date: 2026/10/29 · Site observation date: 2026/10/30
View source ↗ - 2026/10/28No longer listed under review
No verified English name
CYSB2600237
Fact date: 2026/10/28 · Site observation date: 2026/10/28
Accepted: 2026/08/04
not on the CDE under-review list in this snapshot; NMPA published approval-document delivery for this acceptance number on 2026/10/28 (approval no.: —; approval date: 2026/10/26); this is a supplemental application, not counted as a new marketing approval · NMPA source · row 18
NMPA · Table row 18 ↗ View source ↗ - 2026/10/27No longer listed under review
No verified English name
CXSB2600210
Fact date: 2026/10/27 · Site observation date: 2026/10/27
Accepted: 2026/08/17
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/26Supplement delivery
No verified English name
CYSB2600237
Fact date: 2026/10/26 · Publication date: 2026/10/28 · Site observation date: 2026/11/03
Supplemental application; excluded from new marketing approvals.
View source · Table row 18 ↗ - 2026/10/21Notification delivery
No verified English name
CYHS2502034
Fact date: 2026/10/21 (Publication date) · Publication date: 2026/10/21 · Site observation date: 2026/11/03
Notification delivered; the specific outcome remains to be checked.
View source · Table row 8 ↗ - 2026/10/20Marketing application approved
Ponatinib Tablets
CYHS2502789 · 国药准字H20266345
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
View source · Table row 97 ↗ - 2026/08/27Accepted
No verified English name
CYSB2600265
Fact date: 2026/08/27 · Site observation date: 2026/10/22
View source ↗ - 2026/08/17Accepted
No verified English name
CXSB2600210
Fact date: 2026/08/17 · Site observation date: 2026/10/22
View source ↗
Under review
37 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | CXHS2600151 | New drug | 2026/11/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXHS2600150 | New drug | 2026/11/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXHS2600149 | New drug | 2026/11/09 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXSL2601229 | New drug | 2026/11/05 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Crisaborole Ointment | CYHB2601976 | Supplement | 2026/10/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Crisaborole Ointment | CYHB2601975 | Supplement | 2026/10/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYSB2600265 | Supplement | 2026/08/27 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Idebenone Tablets | CYHS2602008 | Generic | 2026/08/13 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXHS2600109 | New drug | 2026/07/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXHS2600108 | New drug | 2026/07/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXHS2600107 | New drug | 2026/07/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2601568 | Generic | 2026/07/02 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2601567 | Generic | 2026/07/02 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXSS2600102 | New drug | 2026/06/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXSS2600101 | New drug | 2026/06/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYSB2600157 | Supplement | 2026/05/29 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXSS2600072 | New drug | 2026/04/24 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYSB2600112 | Supplement | 2026/03/31 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYSB2600109 | Supplement | 2026/03/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2600627 | Generic | 2026/03/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2600626 | Generic | 2026/03/16 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYSB2600094 | Supplement | 2026/03/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYSB2600093 | Supplement | 2026/03/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYSB2600085 | Supplement | 2026/03/02 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Palonosetron Hydrochloride Soft Capsules | CYHS2600241 | Generic | 2026/01/20 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYSB2600005 | Supplement | 2026/01/08 | Qilu Pharmaceutical Co., Ltd.; Jiangsu Tai Kang Biopharmaceuticals Co., Ltd. romanized | CDE ↗ |
| Budesonide Gastro-Resistant Capsules | CYHS2504066 | Generic | 2025/11/25 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Triptorelin Acetate For Injection | CYHS2504016 | Generic | 2025/11/19 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYSB2500265 | Supplement | 2025/10/10 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2503262 | Generic | 2025/09/04 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2503261 | Generic | 2025/09/04 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2503012 | Generic | 2025/08/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2503011 | Generic | 2025/08/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ruxolitinib Phosphate Tablets | CYHS2503010 | Generic | 2025/08/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2502234 | Generic | 2025/06/20 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXHS2400095 | New drug | 2024/09/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CXHS2400094 | New drug | 2024/09/15 | Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
215 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Safinamide Methansulfonate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20264605 | 2026/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Safinamide Methansulfonate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20264604 | 2026/06/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20264449 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20264451 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20264450 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20264371 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20264370 | 2026/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Orally Disintegrating Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20263260 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Orally Disintegrating Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20263259 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Orally Disintegrating Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20263258 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lusutrombopag Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20263125 | 2026/01/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Letermovir Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20256326 | 2025/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Letermovir Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20256325 | 2025/12/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20256227 | 2025/12/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Brexpiprazole Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20256228 | 2025/12/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Letermovir Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20256071 | 2025/11/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Entacapone,Levodopa and Carbidopa Tablets（Ⅱ） | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20255859 | 2025/11/04 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Netupitant and Palonosetron Hydrochloride Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20255060 | 2025/07/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dronedarone Hydrochloride Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20254815 | 2025/07/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ethyl Iosapentate Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20254765 | 2025/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20254739 | 2025/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin and Metformin Hydrochloride Sustained-release Tablets (Ⅰ) | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20253377 | 2025/02/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20253378 | 2025/02/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ciclosporin Soft Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20253311 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ixazomib Citrate Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20253310 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ciclosporin Soft Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20253226 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ixazomib Citrate Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20253308 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ixazomib Citrate Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20253309 | 2025/01/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Edoxaban Tosilate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20253108 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Edoxaban Tosilate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20253109 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Edoxaban Tosilate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20253107 | 2025/01/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20249824 | 2024/12/25 | Not stated by source | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20249825 | 2024/12/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levofolinate Calcium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20100155 | 2024/12/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20249570 | 2024/12/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Levofolinate Calcium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20184093 | 2024/11/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Riociguat Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244960 | 2024/09/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Riociguat Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244959 | 2024/09/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Riociguat Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244958 | 2024/09/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Omega-3-acid ethyl ester 90 Soft Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244779 | 2024/09/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dalteparin Sodium Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20247201 | 2024/09/02 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Dapagliflozin Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244734 | 2024/08/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapagliflozin Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244735 | 2024/08/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bambuterol Hydrochloride Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20010100 | 2024/08/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ganirelix Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244467 | 2024/07/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Avatrombopag Maleate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244402 | 2024/07/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Macitentan Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244255 | 2024/06/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244031 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244032 | 2024/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tafamidis Meglumine Soft Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243999 | 2024/06/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10970061 | 2024/06/05 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243808 | 2024/05/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243809 | 2024/05/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243810 | 2024/05/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243811 | 2024/05/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243651 | 2024/04/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carvedilol Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20020547 | 2024/04/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Regorafenib Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243570 | 2024/04/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carvedilol Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20020535 | 2024/04/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cetrorelix Acetate for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243480 | 2024/04/11 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Mirabegron Extended-release Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243088 | 2024/01/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Eltrombopag Olamine Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20243007 | 2024/01/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amikacin Sulfate injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H37020562 | 2023/12/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Alprazolam Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H37021277 | 2023/11/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esomeprazole Sodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20183454 | 2023/11/03 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sildenafil Citrate Oral Disintegrating Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20234459 | 2023/10/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Azithromycin For Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20237135 | 2023/10/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Rivaroxaban Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20237112 | 2023/09/28 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dolutegravir Sodium Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20234126 | 2023/09/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Octreotide Acetate Microspheres for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233997 | 2023/08/01 | Not stated by source | CDE ↗ |
| Fulvestrant Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233976 | 2023/08/01 | Not stated by source | CDE ↗ |
| Octreotide Acetate Microspheres for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233996 | 2023/08/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nintedanib Esilate Soft Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233842 | 2023/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nintedanib Esilate Soft Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233841 | 2023/06/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Canagliflozin Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233740 | 2023/06/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Canagliflozin Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233741 | 2023/06/21 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233632 | 2023/05/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233634 | 2023/05/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233633 | 2023/05/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nilotinib Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233282 | 2023/03/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Nilotinib Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233281 | 2023/03/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pazopanib Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233248 | 2023/03/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sildenafil Citrate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20237025 | 2023/03/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Probucol Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20237019 | 2023/02/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lenvatinib Mesilate Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20237013 | 2023/02/03 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Enzalutamide Soft Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20233027 | 2023/01/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Esomeprazole Sodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20183455 | 2023/01/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10980198 | 2022/12/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Emtricitabine and Tenofovir Alafenamide Fumarate Tablets（Ⅱ） | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20223826 | 2022/11/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20223788 | 2022/11/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Linagliptin Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20223786 | 2022/11/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20223789 | 2022/11/01 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20223623 | 2022/08/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dutasteride Soft Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20223596 | 2022/08/10 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carboplatin Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20020180 | 2022/06/17 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Carboplatin Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20227082 | 2022/06/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Carboplatin Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20227083 | 2022/06/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tofacitinib Citrate Extended Release tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20223241 | 2022/04/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefprozil Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20223209 | 2022/04/08 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Carvedilol Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20000100 | 2022/03/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Docetaxel Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20031244 | 2022/03/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Isosorbide Dinitrate Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10960035 | 2022/01/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Isosorbide Dinitrate Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10960036 | 2022/01/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Clozapine Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H37022820 | 2021/11/24 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nedaplatin For Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20217121 | 2021/11/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nedaplatin For Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20217122 | 2021/11/22 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Esmolol Hydrochloride Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H19991059 | 2021/11/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Zopiclone Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10980163 | 2021/10/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Zopiclone Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10980162 | 2021/10/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime And Avibactam Sodium For Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213758 | 2021/09/30 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H37021289 | 2021/09/23 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lenvatinib Mesilate Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213718 | 2021/09/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Granisetron Hydrochloride injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20205022 | 2021/09/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sodium Ibandronate Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183019 | 2021/07/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sodium Ibandronate Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183018 | 2021/07/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sodium Ibandronate Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183020 | 2021/07/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213535 | 2021/06/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213536 | 2021/06/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213534 | 2021/06/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rasagiline Mesylate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213529 | 2021/06/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Docetaxel Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20205004 | 2021/06/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Nedaplatin For Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20050563 | 2021/06/11 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Edaravone Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183405 | 2021/05/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Biapenem For Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213390 | 2021/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213380 | 2021/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213381 | 2021/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Rivaroxaban Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213382 | 2021/05/19 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20040422 | 2021/05/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefminox Sodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20058804 | 2021/04/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefminox Sodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20058805 | 2021/04/29 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Granisetron Hydrochloride injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20054797 | 2021/04/21 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Emtricitabine and tenofovir disoproxil fumarate tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213275 | 2021/04/13 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20060512 | 2021/04/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ropivacaine hydrochloride injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20153781 | 2021/04/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ropivacaine hydrochloride injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20153780 | 2021/04/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ropivacaine hydrochloride injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20052716 | 2021/04/06 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20013075 | 2021/03/18 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Docetaxel Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20041129 | 2021/03/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Saxagliptin Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213188 | 2021/03/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Saxagliptin Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213189 | 2021/03/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Zoledronic Acid Concentrated Solution for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183480 | 2021/02/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Docetaxel Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20041128 | 2021/02/04 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Fosaprepitant Dimeglumine for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213106 | 2021/02/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ondansetron Hydrochloride Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10970064 | 2021/01/27 | Not stated by source | CDE ↗ |
| Ondansetron Hydrochloride Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10970065 | 2021/01/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213044 | 2021/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Pemetrexed Disodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20060672 | 2021/01/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Pemetrexed Disodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20103287 | 2021/01/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Emtricitabine Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20213007 | 2021/01/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Abiraterone Acetate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20205060 | — | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Ceftriaxone Sodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20013032 | 2020/12/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H37020572 | 2020/12/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftriaxone Sodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H37020573 | 2020/12/31 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Trifluridine and Tipiracil Hydrochloride Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203732 | 2020/12/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Trifluridine and Tipiracil Hydrochloride Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203731 | 2020/12/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203683 | 2020/12/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203685 | 2020/12/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Palbociclib Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203684 | 2020/12/15 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Irsogladine Maleate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10980048 | 2020/12/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Irsogladine Maleate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10980047 | 2020/12/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tenofovir alafenamide Fumarate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203610 | 2020/11/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Bortezomib For Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183102 | 2020/10/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Bortezomib For Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183101 | 2020/10/19 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Parecoxib Sodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183180 | 2020/10/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Parecoxib Sodium for Injection | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183179 | 2020/10/13 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Afatinib Dimaleate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203460 | 2020/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Afatinib Dimaleate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203459 | 2020/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Afatinib Dimaleate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203458 | 2020/09/02 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sildenafil Citrate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203389 | 2020/08/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sildenafil Citrate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203388 | 2020/08/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sildenafil Citrate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203387 | 2020/08/05 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aprepitant Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203322 | 2020/07/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Aprepitant Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203321 | 2020/07/16 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Isosorbide Mononitrate Extended-Release Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20066717 | 2020/07/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Isosorbide Mononitrate Extended-Release Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20066716 | 2020/07/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olmesartan Medoxomil Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203251 | 2020/06/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olmesartan Medoxomil Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203250 | 2020/06/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20080301 | 2020/06/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Entecavir Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203225 | 2020/05/26 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Leflunomide Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203195 | 2020/05/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Leflunomide Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203194 | 2020/05/07 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lenalidomide Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20204028 | 2020/05/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lenalidomide Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20204027 | 2020/05/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Lenalidomide Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20204026 | 2020/05/06 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Abiraterone Acetate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20203167 | 2020/04/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Capecitabine Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20143365 | 2020/01/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ondansetron Hydrochloride Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10970062 | 2019/12/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tofacitinib Citrate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20193295 | 2019/10/23 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20193275 | 2019/09/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20193274 | 2019/09/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20193273 | 2019/09/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Etoricoxib Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20193272 | 2019/09/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Warfarin Sodium Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H37021314 | 2019/09/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Risperidone Orally Disintegrating Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20070271 | 2019/08/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Risperidone Orally Disintegrating Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20070319 | 2019/08/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amisulpride Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20113231 | 2019/08/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Amisulpride Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20113230 | 2019/08/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Lenalidomide Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20193115 | 2019/04/25 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Adefovir Dipivoxil Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20080032 | 2019/04/15 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tegafur，Gimeracil and Oteracil Potassium Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20100151 | 2019/02/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tegafur，Gimeracil and Oteracil Potassium Capsules | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20100150 | 2019/02/26 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Trimetazidine Dihydrochloride Modified Release Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20193055 | 2019/02/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Risperidone Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20050042 | 2019/01/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Risperidone Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20041808 | 2019/01/30 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ondansetron Hydrochloride Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10970063 | 2019/01/16 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Terbinafine Hydrochloride Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H10970218 | — | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Olanzapine Orally Disintegrating Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183512 | 2018/12/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine Orally Disintegrating Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183511 | 2018/12/24 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Solifenacin Succinate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183497 | 2018/12/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Solifenacin Succinate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183498 | 2018/12/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183501 | 2018/12/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Olanzapine Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20183500 | 2018/12/17 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tenofovir Disoproxil Fumarate Tablets | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20173185 | 2018/02/08 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized | 国药准字H20163465 | 2017/12/27 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical Co., Ltd. | 国药准字H20244430 | 2024/07/09 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
117 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20260000864 | I | 2026/10/13 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20260000710 | I | 2026/08/25 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20250000994 | I | 2025/09/29 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20250000504 | I | 2025/07/04 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20250000174 | A | 2026/09/14 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20240001103 | A | 2026/03/26 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20240001040 | I | 2026/01/06 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20240000820 | I | 2024/09/02 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20240000576 | A | 2026/01/25 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20240000577 | A | 2025/09/30 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20240000333 | A | 2025/09/11 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20230001161 | A | 2025/08/28 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20230000836 | A | 2025/10/14 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20230000721 | A | 2026/05/22 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20230000403 | A | 2025/08/01 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20230000382 | A | 2024/07/23 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20230000168 | A | 2025/08/01 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20230000253 | A | 2024/06/28 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20230000191 | A | 2024/10/25 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20220001096 | A | 2024/08/09 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20220000970 | A | 2024/07/19 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20220000855 | A | 2024/11/28 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20210001240 | A | 2026/08/12 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20210000560 | A | 2023/04/21 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20200001256 | A | 2022/08/03 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20200001210 | A | 2023/06/30 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190021285 | I | 2022/07/20 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190009892 | A | 2024/01/18 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190009825 | A | 2024/01/17 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190009791 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190009777 | A | 2025/11/12 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190009406 | A | 2024/10/24 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190009403 | A | 2024/11/21 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190009396 | A | 2024/09/04 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190009394 | A | 2024/09/26 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190009353 | A | 2025/02/27 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190008342 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190008220 | A | 2025/11/12 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190006800 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190006703 | A | 2026/07/24 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190006635 | A | 2026/06/11 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190006634 | A | 2026/06/11 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190006631 | A | 2026/06/11 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190006422 | A | 2025/11/13 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190006334 | A | 2026/10/27 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190006207 | A | 2025/04/15 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190006037 | A | 2026/06/17 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190003054 | A | 2024/11/22 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190002993 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190002842 | A | 2024/11/21 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190002762 | A | 2024/11/21 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190002361 | A | 2025/03/22 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190002359 | A | 2024/09/05 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001610 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001606 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001603 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001602 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001601 | A | 2026/03/12 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001600 | A | 2025/01/27 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001591 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001581 | A | 2024/10/24 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001577 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001576 | A | 2024/11/21 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001572 | A | 2024/10/24 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001571 | A | 2024/11/21 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001569 | A | 2026/11/05 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001568 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001567 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001565 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001560 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001557 | A | 2026/03/13 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001556 | A | 2026/08/07 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001554 | A | 2024/10/24 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001548 | A | 2024/09/26 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001547 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001546 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001545 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001542 | A | 2024/08/07 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001539 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001527 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190001526 | A | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190000713 | A | 2026/04/27 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190000650 | A | 2026/04/27 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20190000124 | A | 2025/10/16 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001627 | I | 2019/02/03 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001651 | I | 2019/02/03 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001653 | I | 2019/02/03 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001623 | A | 2024/11/07 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001628 | A | 2025/04/15 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001634 | A | 2026/08/12 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001626 | A | 2019/01/02 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001325 | A | 2026/09/01 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001049 | A | 2025/07/18 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001114 | I | 2018/09/12 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001048 | A | 2025/08/22 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001071 | A | 2025/04/15 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180001051 | A | 2025/05/24 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20180000930 | A | 2026/04/22 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170002205 | A | 2024/09/26 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170002192 | A | 2026/06/11 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170001651 | A | 2026/01/29 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170001581 | A | 2024/09/03 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170001576 | A | 2024/12/31 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170001471 | A | 2024/10/24 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170001341 | I | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170001127 | A | 2024/09/03 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170000995 | I | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170000572 | A | 2024/04/16 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170000569 | A | 2024/09/04 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170000507 | A | 2024/09/03 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170000458 | A | 2024/11/07 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170000414 | A | 2024/09/26 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170000380 | I | — | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170000333 | A | 2024/09/03 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170000286 | A | 2024/09/03 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20170000036 | A | 2024/09/03 | CDE ↗ |
| No verified English name | Qilu Pharmaceutical Co., Ltd. | Y20260000925 | I | 2026/11/03 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
97 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Atorvastatin Calcium Tablets | CYHB2601485 | Supplement | 2026/08/03 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Atorvastatin Calcium Tablets | CYHB2601484 | Supplement | 2026/08/03 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Amikacin Sulfate injection | CYHS2600409 | Generic | 2026/02/06 | Shandong An Xin Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTS2500144 | Not stated by source | 2025/11/26 | AstraZeneca AB; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2502286 | Supplement | 2025/11/05 | Shandong Bo Shi Lun Fu Rui Da Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2500124 | Not stated by source | 2025/08/12 | Chirogate International Inc. Youth Plant; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2500670 | Supplement | 2025/04/03 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2500669 | Supplement | 2025/04/03 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2500668 | Supplement | 2025/04/03 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2500045 | Not stated by source | 2025/03/18 | Chirogate International Inc. Youth Plant; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2400155 | Not stated by source | 2024/08/28 | FARMABIOS S.P.A.; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2400124 | Not stated by source | 2024/08/01 | Chirogate International Inc. Youth Plant; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Tacrolimus Ointment | CYHS2401599 | Generic | 2024/05/29 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2400040 | Not stated by source | 2024/03/19 | FARMABIOS S.P.A.; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTS2300071 | Not stated by source | 2023/12/05 | Eli Lilly and Company; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTS2300051 | Not stated by source | 2023/10/14 | MSD Ireland (Carlow); Merck Sharp & Dohme Corp. a subsidiary of Merck & Co. Inc.; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftazidime for Injection | CYHB2302034 | Supplement | 2023/09/09 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2301752 | Supplement | 2023/08/01 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Terbinafine Hydrochloride Cream | CYHS2301721 | Generic | 2023/06/28 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2301024 | Generic | 2023/04/11 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHS2301023 | Generic | 2023/04/11 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2300010 | Not stated by source | 2023/01/11 | Mylan Laboratories Limited (Unit 1); Mylan Laboratories Limited; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2300061 | Supplement | 2023/01/09 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2300060 | Supplement | 2023/01/09 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2300059 | Supplement | 2023/01/09 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2200204 | Not stated by source | 2022/10/19 | Aurore Pharmaceuticals Private Limited; AURORE LIFE SCIENCES PRIVATE LIMITED; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2200127 | Not stated by source | 2022/07/04 | Aurore Pharmaceuticals Private Limited; AURORE LIFE SCIENCES PRIVATE LIMITED; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Olopatadine Hydrochloride Eye Drops | CYHS2200987 | Generic | 2022/07/02 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftazidime for Injection | CYHB2201050 | Supplement | 2022/06/29 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Atorvastatin Calcium Tablets | CYHB2200905 | Supplement | 2022/06/08 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd.; Hainan Huang Long Pharmaceutical Co., Ltd. romanized | CDE ↗ |
| Atorvastatin Calcium Tablets | CYHB2200904 | Supplement | 2022/06/08 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Sodium Hyaluronate Eye Drops | CYHS2200831 | Generic | 2022/06/03 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefazolin Sodium for Injection | CYHB2200862 | Supplement | 2022/06/02 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefazolin Sodium for Injection | CYHB2200861 | Supplement | 2022/06/02 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2200072 | Not stated by source | 2022/04/06 | Aarti Industries Limited; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2200039 | Not stated by source | 2022/03/01 | MEHTA API PVT. LTD.; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Sodium Hyaluronate Eye Drops | CYHS2102230 | Generic | 2021/12/20 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Sodium Hyaluronate Eye Drops | CYHS2102229 | Generic | 2021/12/20 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Bromfenac Sodium Eye Drops | CYHS2102228 | Generic | 2021/12/20 | Qi Lu Pharmaceutical (Hainan) Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefazolin Sodium for Injection | CYHB2101830 | Supplement | 2021/09/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefazolin Sodium for Injection | CYHB2101829 | Supplement | 2021/09/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2100594 | Not stated by source | 2021/08/09 | Dr. Reddy’s Laboratories Ltd.; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Biapenem For Injection | CYHB2101385 | Supplement | 2021/06/15 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101134 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101133 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101132 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101131 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101130 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101129 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101128 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101127 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101126 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftazidime for Injection | CYHB2101125 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101124 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101113 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101110 | Supplement | 2021/04/16 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2101123 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2101122 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefotaxime Sodium For Injection | CYHB2101121 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefazolin Sodium for Injection | CYHB2101120 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefazolin Sodium for Injection | CYHB2101119 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefoxitin Sodium for Injection | CYHB2101118 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefoxitin Sodium for Injection | CYHB2101116 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefminox Sodium for Injection | CYHB2101114 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefminox Sodium for Injection | CYHB2101112 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefminox Sodium for Injection | CYHB2101111 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefuroxime Sodium for Injection | CYHB2101109 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefuroxime Sodium for Injection | CYHB2101108 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefuroxime Sodium for Injection | CYHB2101107 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefuroxime Sodium for Injection | CYHB2101106 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefuroxime Sodium for Injection | CYHB2101105 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2101104 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2101103 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Ceftriaxone Sodium for Injection | CYHB2101102 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefodizime Sodium for Injection | CYHB2101101 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefodizime Sodium for Injection | CYHB2101100 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefodizime Sodium for Injection | CYHB2101099 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CYHB2101098 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | CYHB2101097 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefoperazone Sodium For Injection | CYHB2101096 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefoperazone Sodium For Injection | CYHB2101095 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefoperazone Sodium For Injection | CYHB2101094 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101093 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101092 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101091 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101090 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101089 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefalexin Capsules | CYHB2101088 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefalexin Capsules | CYHB2101087 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101086 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefalexin Tablets | CYHB2101085 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101084 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101083 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | CYHB2101082 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefteram Pivoxil Tablets | CYHB2101081 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| Cefteram Pivoxil Tablets | CYHB2101080 | Supplement | 2021/04/14 | Qi Lu An Ti Pharmaceutical Co., Ltd. romanized; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
| No verified English name | JTH2000399 | Not stated by source | 2021/01/04 | BASF Pharma（Callanish）Ltd.; BASF AS; Qilu Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.